Conway, Kevin P. Swendsen, Joel Husky, Mathilde M. He, Jian-Ping and Merikangas, Kathleen R. 2016. Association of Lifetime Mental Disorders and Subsequent Alcohol and Illicit Drug Use: Results From the National Comorbidity Survey–Adolescent Supplement. Journal of the American Academy of Child & Adolescent Psychiatry, Vol. 55, Issue. 4, p. 280.
Kolla, Nathan J. van der Maas, Mark Toplak, Maggie E. Erickson, Patricia G. Mann, Robert E. Seeley, Jane and Vingilis, Evelyn 2016. Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey. BMC Psychiatry, Vol. 16, Issue. 1,
Serafini, Kelly Malin-Mayor, Bo Nich, Charla Hunkele, Karen and Carroll, Kathleen M. 2016. Psychometric properties of the Positive and Negative Affect Schedule (PANAS) in a heterogeneous sample of substance users. The American Journal of Drug and Alcohol Abuse, Vol. 42, Issue. 2, p. 203.
Squeglia, Lindsay M. Brammer, Whitney A. Ray, Lara A. and Lee, Steve S. 2016. Attention Deficit/Hyperactivity Disorder (ADHD) Symptoms Predict Alcohol Expectancy Development. Journal of Child & Adolescent Substance Abuse, Vol. 25, Issue. 2, p. 169.
Canela, Carlos Schleifer, Roman Jeger, Jörg Ebner, Gerhard Seifritz, Erich and Liebrenz, Michael 2015. Die invalidenversicherungsrechtliche Begutachtung in der Schweiz vor dem Hintergrund der letzten Gesetzesrevision und neueren Rechtsprechung. Forensische Psychiatrie, Psychologie, Kriminologie, Vol. 9, Issue. 2, p. 106.
Degenhardt, Louisa and Hall, Wayne D. 2015. The Handbook of Drugs and Society.
Hollen, Vera and Ortiz, Glorimar 2015. Mental Health and Substance Use Comorbidity Among Adolescents in Psychiatric Inpatient Hospitals: Prevalence and Covariates. Journal of Child & Adolescent Substance Abuse, Vol. 24, Issue. 2, p. 102.
Koob, George F. Kandel, Denise B. Baler, Ruben D. and Volkow, Nora D. 2015. Psychiatry.
Lopez-Quintero, Catalina and Anthony, James C. 2015. Drug use disorders in the polydrug context: new epidemiological evidence from a foodborne outbreak approach. Annals of the New York Academy of Sciences, Vol. 1349, Issue. 1, p. 119.
Newville, Howard Berg, Karina M. and Gonzalez, Jeffrey S. 2015. The Interaction of Active Substance Use, Depression, and Antiretroviral Adherence in Methadone Maintenance. International Journal of Behavioral Medicine, Vol. 22, Issue. 2, p. 214.
Slade, T. McEvoy, P. M. Chapman, C. Grove, R. and Teesson, M. 2015. Onset and temporal sequencing of lifetime anxiety, mood and substance use disorders in the general population. Epidemiology and Psychiatric Sciences, Vol. 24, Issue. 01, p. 45.
Alizadeh, Azizeh Azizi, Maryam Barati, Mohamad Soleimani, Fatemeh Morad, Rezvaneh Rahnejat, Amirhosein and Donyavi, Vahid 2014. Psychotherapy and the Length of Hospitalization in the Patients With Mental Disorders: A 2-Year Follow-up Study. Journal of Archives in Military Medicine, Vol. 2, Issue. 4,
Asbridge, Mark Azagba, Sunday Langille, Donald B and Rasic, Daniel 2014. Elevated depressive symptoms and adolescent injury: examining associations by injury frequency, injury type, and gender. BMC Public Health, Vol. 14, Issue. 1,
De Alwis, Duneesha Lynskey, Michael T. Reiersen, Angela M. and Agrawal, Arpana 2014. Attention-deficit/hyperactivity disorder subtypes and substance use and use disorders in NESARC. Addictive Behaviors, Vol. 39, Issue. 8, p. 1278.
Di Florio, A. Craddock, N. and van den Bree, M. 2014. Alcohol misuse in bipolar disorder. A systematic review and meta-analysis of comorbidity rates. European Psychiatry, Vol. 29, Issue. 3, p. 117.
Easton, A C Lourdusamy, A Havranek, M Mizuno, K Solati, J Golub, Y Clarke, T-K Vallada, H Laranjeira, R Desrivières, S Moll, G H Mössner, R Kornhuber, J Schumann, G Giese, K P Fernandes, C Quednow, B B and Müller, C P 2014. αCaMKII controls the establishment of cocaine's reinforcing effects in mice and humans. Translational Psychiatry, Vol. 4, Issue. 10, p. e457.
Tarter, Ralph Kirisci, Levent and Reynolds, Maureen 2014. A New Approach to Researching the Etiology of Cannabis Use Disorder: Integrating Transmissible and Nontransmissible Risk Within a Developmental Framework. Substance Abuse, Vol. 35, Issue. 4, p. 336.
Wang, Mei Finch, Emily and Wolff, Kim 2014. Psychiatric co-morbidity among subjects with heroin and cocaine use disorders and its association with HCV infection. Journal of Substance Use, Vol. 19, Issue. 3, p. 245.
Weinberg, Naimah Lopez, Marsha and Compton, Wilson M. 2014. The Effects of Drug Abuse on the Human Nervous System.
Copeland, William E. Adair, Carol E. Smetanin, Paul Stiff, David Briante, Carla Colman, Ian Fergusson, David Horwood, John Poulton, Richie Jane Costello, E. and Angold, Adrian 2013. Diagnostic transitions from childhood to adolescence to early adulthood. Journal of Child Psychology and Psychiatry, Vol. 54, Issue. 7, p. 791.
Although mental disorders have been shown to predict subsequent substance disorders, it is not known whether substance disorders could be cost-effectively prevented by large-scale interventions aimed at prior mental disorders. Although experimental intervention is the only way to resolve this uncertainty, a logically prior question is whether the associations of mental disorders with subsequent substance disorders are strong enough to justify mounting such an intervention. We investigated this question in this study using simulations to estimate the number of substance disorders that might be prevented under several hypothetical intervention scenarios focused on mental disorders.
Data came from the National Comorbidity Survey Replication (NCS-R), a nationally representative US household survey that retrospectively assessed lifetime history and age of onset of DSM-IV mental and substance disorders. Survival analysis using retrospective age-of-onset reports was used to estimate associations of mental disorders with subsequent substance dependence. Simulations based on the models estimated effect sizes in several hypothetical intervention scenarios.
Although successful intervention aimed at mental disorders might prevent some proportion of substance dependence, the number of cases of mental disorder that would have to be treated to prevent a single case of substance dependence is estimated to be so high that this would not be a cost-effective way to prevent substance dependence (in the range 76–177 for anxiety-mood disorders and 40–47 for externalizing disorders).
Treatment of prior mental disorders would not be a cost-effective way to prevent substance dependence. However, prevention of substance dependence might be considered an important secondary outcome of interventions for early-onset mental disorders.
This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.